Search papers, labs, and topics across Lattice.
Department of Radiation Oncology, The First Affiliated Hospital of Bengbu Medical University, Joint Research Center for Regional Diseases of Institute of Health and Medicine (IHM), Bengbu Medical University
1
0
0
7
Adding anlotinib to radiotherapy and immunotherapy for advanced NSCLC improves progression-free survival, but the increased toxicity and lack of overall survival benefit warrant careful consideration.